Frontiers in cancer immunology. (Record no. 133701)

MARC details
000 -LEADER
fixed length control field 01849nam a2200421 i 4500
001 - CONTROL NUMBER
control field EBC2048563
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240121040819.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150526t20152015ts ob 001 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781681080499
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781681080482 (e-book)
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC2048563
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL2048563
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr11054736
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)939554532
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC271.I45
Item number .F76 2015
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.994061
Edition number 23
245 00 - TITLE STATEMENT
Title Frontiers in cancer immunology.
Number of part/section of a work Volume 1,
Name of part/section of a work Cancer immunotherapy :
Remainder of title mechanisms of cancer immunity, engineering immune-based therapies and developing clinical trials /
Statement of responsibility, etc. editor, Jianxun Song.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Sharjah, United Arab Emirates :
Name of producer, publisher, distributor, manufacturer Bentham Science Publishers,
Date of production, publication, distribution, manufacture, or copyright notice 2015.
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 2015
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (283 pages)
336 ## - CONTENT TYPE
Content type term text
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on online resource; title from PDF title page (ebrary, viewed May 23, 2015).
590 ## - LOCAL NOTE (RLIN)
Local note Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer
General subdivision Immunotherapy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Song, Jianxun ,
Relator term editor.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Frontiers in cancer immunology. Volume 1, Cancer immunotherapy.
Place, publisher, and date of publication Sharjah, United Arab Emirates : Bentham Science Publishers, c2015
Physical description 274 pages
International Standard Book Number 9781681080499
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN)
Corporate name or jurisdiction name as entry element ProQuest (Firm)
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=2048563">https://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=2048563</a>
Public note Click to View

No items available.